Literature DB >> 20437820

Effects of the general anaesthetic agent, propofol, on erythrocyte deformability.

Mustafa Arslan1, Faruk Metin Comu, Berrin Isik, Yusuf Unal, Nedim Cekmen, Omer Kurtipek.   

Abstract

OBJECTIVES: Propofol is an anesthetic agent frequently used for sedation and general anesthesia. The purpose of our study was to investigate the effect of propofol, a general anesthetic, on erythrocyte deformability in rats.
METHODOLOGY: The study was performed on 20 male and 20 female rats, with 10 rats in each study group and 10 rats in each control group. The rats in the study group were administered propofol (150 mg.kg(-1)) intraperitoneally, and the rats in the control group were administered SF. Erythrocyte packs were prepared using heparinized total blood samples. Deformability measurements were done by erythrocyte suspensions in PBS buffer. A constant flow filtrometer system was used to measure erythrocyte deformability, and the relative resistance was calculated.
RESULTS: The use of propofol resulted in the increase in the relative resistance, which is an indicator for the erythrocyte deformability in both male and female rats (p = 0.002, p = 0.042, respectively).
CONCLUSION: A negative change in the erythrocyte deformability may cause a functional deterioration in blood flow and tissue perfusion (Fig. 1, Ref. 23).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20437820

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  2 in total

1.  Effects of dexmedetomidine on the deformability of erythrocytes in vitro and in anesthesia.

Authors:  Xiao-Ming Yang; Jun Liu; Jun Ji; Jie Xie
Journal:  Exp Ther Med       Date:  2014-03-27       Impact factor: 2.447

2.  Effect of picroside II on erythrocyte deformability and lipid peroxidation in rats subjected to hind limb ischemia reperfusion injury.

Authors:  Faruk Metin Çomu; Yiğit Kılıç; Abdullah Özer; Mehmet Kirişçi; Ali Doğan Dursun; Tolga Tatar; Mustafa Hakan Zor; Hakan Kartal; Ayşegül Küçük; Hakan Boyunağa; Mustafa Arslan
Journal:  Drug Des Devel Ther       Date:  2016-03-01       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.